• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊肾病2基因(PKD2)外显子结构的特征分析。

Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2).

作者信息

Hayashi T, Mochizuki T, Reynolds D M, Wu G, Cai Y, Somlo S

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Genomics. 1997 Aug 15;44(1):131-6. doi: 10.1006/geno.1997.4851.

DOI:10.1006/geno.1997.4851
PMID:9286709
Abstract

PKD2, the gene defective in the second form of autosomal dominant polycystic kidney disease (ADPKD), has been identified by positional cloning and found to encode an integral membrane protein with similarity to the gene for the more common form of ADPKD and to calcium channels. We have determined the exon-intron structure of the PKD2 gene. PKD2 is encoded in at least 15 exons with the translation start site in exon 1. All the splice acceptor and donor sites conform to the AG/GT rule. We have designed a series of intronic oligonucleotide primers for amplifying the entire coding sequence from genomic DNA in segments well suited to mutation analysis using conventional screening strategies such as SSCA or heteroduplex analysis.

摘要

多囊肾病2(PKD2)基因,是常染色体显性多囊肾病(ADPKD)第二种类型中的缺陷基因,已通过定位克隆被识别出来,并且发现它编码一种整合膜蛋白,该蛋白与更常见类型的ADPKD基因以及钙通道基因具有相似性。我们已经确定了PKD2基因的外显子-内含子结构。PKD2至少由15个外显子编码,其翻译起始位点位于外显子1。所有的剪接受体和供体位点均符合AG/GT规则。我们设计了一系列内含子寡核苷酸引物,用于从基因组DNA中分段扩增整个编码序列,这些片段非常适合使用诸如单链构象多态性分析(SSCA)或异源双链分析等传统筛选策略进行突变分析。

相似文献

1
Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2).多囊肾病2基因(PKD2)外显子结构的特征分析。
Genomics. 1997 Aug 15;44(1):131-6. doi: 10.1006/geno.1997.4851.
2
[Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].[多囊肾病1型和2型(常染色体显性遗传多囊肾病)基因的突变分析]
Nefrologia. 2000 Jan-Feb;20(1):39-46.
3
PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.患有常染色体显性多囊肾病的捷克人群中的PKD2突变
Nephrol Dial Transplant. 2004 May;19(5):1116-22. doi: 10.1093/ndt/gfh083. Epub 2004 Feb 19.
4
Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).与常染色体显性多囊肾病基因(PKD1和PKD2)同源的基因。
Eur J Hum Genet. 1999 Dec;7(8):860-72. doi: 10.1038/sj.ejhg.5200383.
5
Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中PKD1和PKD2基因突变的基因组分析新方法。
Hum Mutat. 2009 Feb;30(2):264-73. doi: 10.1002/humu.20842.
6
Cloning and characterization of the murine pkd2 promoter.小鼠多囊蛋白2启动子的克隆与特性分析
Genomics. 2000 Jun 15;66(3):305-12. doi: 10.1006/geno.2000.6197.
7
Mutations of the PKD2 gene in Taiwanese patients with autosomal dominant polycystic kidney disease.台湾常染色体显性多囊肾病患者中PKD2基因的突变
Ren Fail. 2005;27(1):95-100.
8
PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.斯洛文尼亚常染色体显性多囊肾病家族中的PKD1和PKD2突变
BMC Med Genet. 2006 Jan 23;7:6. doi: 10.1186/1471-2350-7-6.
9
PKD2 gene mutation analysis in Korean autosomal dominant polycystic kidney disease patients using two-dimensional gene scanning.使用二维基因扫描对韩国常染色体显性多囊肾病患者进行PKD2基因突变分析
Clin Genet. 2006 Dec;70(6):502-8. doi: 10.1111/j.1399-0004.2006.00721.x.
10
A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1.一种缺少第7外显子的多囊蛋白-2剪接形式不与多囊蛋白-1相互作用。
Hum Mol Genet. 2005 Nov 1;14(21):3249-62. doi: 10.1093/hmg/ddi356. Epub 2005 Sep 28.

引用本文的文献

1
Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids.腺嘌呤碱基编辑器纠正了人诱导多能干细胞和肾类器官中的常染色体显性多囊肾病点突变。
Adv Biotechnol (Singap). 2024 Jun 11;2(2):20. doi: 10.1007/s44307-024-00026-8.
2
Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations.利用PKD1/PKD2突变预测常染色体显性多囊肾病患者的肾脏预后
J Clin Med. 2020 Jan 5;9(1):146. doi: 10.3390/jcm9010146.
3
Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients.
日本常染色体显性多囊肾病患者的下一代测序和多重连接依赖探针扩增突变分析。
Clin Exp Nephrol. 2019 Aug;23(8):1022-1030. doi: 10.1007/s10157-019-01736-3. Epub 2019 Apr 15.
4
Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD.鉴定 125 例亚洲裔常染色体显性多囊肾病患者 PKD1 和 PKD2 基因突变。
J Hum Genet. 2019 May;64(5):409-419. doi: 10.1038/s10038-019-0582-8. Epub 2019 Feb 28.
5
Mutational screening of PKD2 gene in the north Indian polycystic kidney disease patients revealed 28 genetic variations.对印度北部多囊肾病患者的PKD2基因进行突变筛查,发现了28种基因变异。
J Genet. 2017 Dec;96(6):885-893. doi: 10.1007/s12041-017-0824-5.
6
High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).高分辨率熔解曲线分析作为常染色体显性多囊肾病(ADPKD)的一种筛查方法
J Clin Lab Anal. 2014 Jul;28(4):328-34. doi: 10.1002/jcla.21689. Epub 2014 Mar 22.
7
Experimental therapies and ongoing clinical trials to slow down progression of ADPKD.减缓常染色体显性多囊肾病进展的实验性疗法及正在进行的临床试验。
Curr Hypertens Rev. 2013 Feb;9(1):44-59. doi: 10.2174/1573402111309010008.
8
Genetic contribution and associated pathophysiology in end-stage renal disease.终末期肾病的遗传贡献及相关病理生理学
Appl Clin Genet. 2010 Aug 5;3:65-84. doi: 10.2147/tacg.s7330. Print 2010.
9
High Resolution Melt analysis for mutation screening in PKD1 and PKD2.高通量熔解曲线分析用于 PKD1 和 PKD2 的突变筛查。
BMC Nephrol. 2011 Oct 18;12:57. doi: 10.1186/1471-2369-12-57.
10
A pathogenic C terminus-truncated polycystin-2 mutant enhances receptor-activated Ca2+ entry via association with TRPC3 and TRPC7.一种致病性C末端截短的多囊蛋白-2突变体通过与TRPC3和TRPC7结合增强受体激活的Ca2+内流。
J Biol Chem. 2009 Dec 4;284(49):34400-12. doi: 10.1074/jbc.M109.015149. Epub 2009 Oct 7.